STOCK TITAN

Marsh & McLennan (MMC) director granted 1,349.82 restricted stock units

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Marsh & McLennan Companies director Jane H. Lute received an equity award through the company’s director stock plan. She was granted 1,349.82 restricted stock units on June 1, 2026, which convert into common stock on a 1-for-1 basis. Following this grant, she holds 8,911.69 derivative shares linked to common stock. The award is classified as a grant or other acquisition, reflecting routine director compensation rather than an open‑market trade.

Positive

  • None.

Negative

  • None.
Insider Lute Jane H
Role null
Type Security Shares Price Value
Grant/Award Restricted Stk. Units-Dir. Stk. Plan 1,349.82 $159.28 $215K
Holdings After Transaction: Restricted Stk. Units-Dir. Stk. Plan — 8,911.69 shares (Direct, null)
Footnotes (1)
  1. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis. Annual stock award of 1,349.82 shares pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan. Not Applicable
RSUs granted 1,349.82 units Annual director stock award on June 1, 2026
Reference price per unit $159.28 per unit Reported transaction price for RSU grant
Total derivative holdings after grant 8,911.69 units Units linked to MMC common stock after transaction
Conversion ratio 1-for-1 Each RSU converts into one common share
Restricted Stk. Units-Dir. Stk. Plan financial
"Restricted Stk. Units-Dir. Stk. Plan"
Directors Stock Compensation Plan financial
"pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
derivative financial
"transaction_type: derivative"
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
1-for-1 basis financial
"converts to Marsh & McLennan Companies common stock on a 1-for-1 basis"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lute Jane H

(Last)(First)(Middle)
C/O MARSH & MCLENNAN COMPANIES, INC.
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MRSH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stk. Units-Dir. Stk. Plan(1)06/01/2026A(2)1,349.82 (3) (3)Common Stock1,349.82$159.288,911.69D
Explanation of Responses:
1. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.
2. Annual stock award of 1,349.82 shares pursuant to the Marsh & McLennan Companies Directors Stock Compensation Plan.
3. Not Applicable
/s/ Tessa Patti, Attorney-in-fact06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MMC director Jane H. Lute report on this Form 4?

Jane H. Lute reported receiving 1,349.82 restricted stock units as a grant under Marsh & McLennan’s Directors Stock Compensation Plan. These units represent routine equity-based director compensation rather than an open-market stock purchase or sale.

How many restricted stock units did MMC grant to director Jane H. Lute?

Marsh & McLennan granted Jane H. Lute 1,349.82 restricted stock units. The filing describes this as an annual stock award issued under the company’s Directors Stock Compensation Plan, providing her with additional equity exposure to Marsh & McLennan common stock.

At what reference price were Jane H. Lute’s MMC restricted stock units valued?

The 1,349.82 restricted stock units granted to Jane H. Lute were valued at a reference price of $159.28 per unit. This price is used for reporting purposes and does not represent an open-market purchase or sale transaction.

How do Jane H. Lute’s MMC restricted stock units convert into common shares?

The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. This means each of the 1,349.82 units will eventually become one share of common stock, subject to the plan’s vesting and distribution terms.

What are Jane H. Lute’s total MMC derivative holdings after this grant?

After receiving 1,349.82 restricted stock units, Jane H. Lute’s total derivative holdings tied to Marsh & McLennan common stock are 8,911.69 units. This figure reflects her position following the reported grant under the directors’ stock compensation plan.